FDA approves Merck/Lilly combo for lung cancer; new PhRMA requirements result in expulsion of 22 members; Pfizer to pay Sangamo $7 million for gene therapy programs
Groups with PhRMA ties warn against drug-pricing proposals; patients learn how to be advocates; the U.K. will not cover Opdivo for head and neck cancer
PhRMA uneasy about “right-to-try” laws
June 18, 2014
5:27 pm
Colorado’s version of the FDA’s compassionate use rule does not sit well with lobbying group Pharmaceutical Research and Manufacturers of America.
Bloomberg scrutinizes drug pricing
May 1, 2014
4:38 pm
An analysis by Bloomberg today shows why drug pricing “keeps defying the law of gravity.”
PhRMA sets up shop in the UAE
October 9, 2013
5:36 pm
The group’s offices will be in the DuBiotech research cluster.
Business briefs: Sanofi, GlaxoSmithKline, AllTrials
August 8, 2013
4:24 pm
Sanofi named in China corruption probe; GlaxoSmithKline starts a venture capital fund; and European non-profit AllTrials outlines its transparency goals
